Add to ORKGBackground and Aims: In Korea, the majority of asthma patients are prescribed dry powder inhalers (DPIs). Patients prescribed inhaled corticosteroid/ long-acting beta agonists (ICS/LABA) may benefit from switching from a DPI to a pressurized Metered Dose Inhaler (pMDI), such as formoterol/fluticasone. The primary aim of this study was to evaluate the 'switch success' of changing asthma patients from ICS/LABA DPIs to formoterol/ fluticasone pMDI in a real-world population in Korea. Secondly, we aim to determine if there are any differences in key clinical parameters (e.g. exacerbations, blood eosinophil counts) between patients who switch inhaler and those who continue on the same inhaler. Methods: Historical cohort database study with basel...
BACKGROUND: Guidelines recommend reducing treatment in patients with well-controlled asthma after 3 ...
SummaryBackgroundSelection of inhaler device type appears to influence real-world effectiveness of i...
BACKGROUND: Inhaled corticosteroids (ICSs) have been shown to reverse epithelial damage and decrease...
Background and Aims: In Korea, the majority of asthma patients are prescribed dry powder inhalers (D...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (L...
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (L...
Background and Aims: Historically, dry powder inhalers (DPIs) were considered to provide better airw...
ABSTRACTBackgroundCombination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agon...
BACKGROUND: Inhaler usability and deposition differ between devices. Change of device may therefore ...
Efficacy trials suggest that extra-fine particle beclometasone dipropionate-formoterol (efBDP-FOR) i...
Introduction In real-life practice, asthma remains poorly controlled, with a considerable burden on ...
Introduction: In recognition of the value of long-term real-world data, a postauthorization safety s...
BACKGROUND: Guidelines recommend reducing treatment in patients with well-controlled asthma after 3 ...
SummaryBackgroundSelection of inhaler device type appears to influence real-world effectiveness of i...
BACKGROUND: Inhaled corticosteroids (ICSs) have been shown to reverse epithelial damage and decrease...
Background and Aims: In Korea, the majority of asthma patients are prescribed dry powder inhalers (D...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (L...
Background: Combination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agonist (L...
Background and Aims: Historically, dry powder inhalers (DPIs) were considered to provide better airw...
ABSTRACTBackgroundCombination therapy with an inhaled corticosteroid (ICS) and a long-acting β2-agon...
BACKGROUND: Inhaler usability and deposition differ between devices. Change of device may therefore ...
Efficacy trials suggest that extra-fine particle beclometasone dipropionate-formoterol (efBDP-FOR) i...
Introduction In real-life practice, asthma remains poorly controlled, with a considerable burden on ...
Introduction: In recognition of the value of long-term real-world data, a postauthorization safety s...
BACKGROUND: Guidelines recommend reducing treatment in patients with well-controlled asthma after 3 ...
SummaryBackgroundSelection of inhaler device type appears to influence real-world effectiveness of i...
BACKGROUND: Inhaled corticosteroids (ICSs) have been shown to reverse epithelial damage and decrease...